Marketing Intern- FUROSCIX at MannKind Corporation | Burlington, MA | SalaryGuide

Marketing Jobs
Field Marketing
Marketing Intern- FUROSCIX

MannKind Corporation

Marketing Intern- FUROSCIX

Burlington, MA (Hybrid)

Salary Not AvailableIntern/New GradFull time

Posted 1 day ago

Job Summary

Original Job Description

MannKind Corporation

Glassdoor

3.6

MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.Please visit mannkindcorp.com to learn more.

Marketing team

22

Employees

803

Headquarters

Danbury, Connecticut, USA

Founded

1991

Employee Sentiment

Overall Rating

3.6 / 5

Recommend to a Friend

79%

CEO Approval

85%

Source: Glassdoor

Traffic Signals

Monthly Visitors

14.4K

Monthly Google Ads Budget

$0.0

Traffic Source Mix

Search

45%

Direct

40.4%

Referral

7.5%

Social

5.6%

Paid

1.4%

Headcount Trend

Current headcount: ~803

Funding

Total Funding

$475.0M

Last Raise

7 months ago

Last Raise Amount

$75.0M

2025-08-06
Post IPO Debt • $75.0M
2021-03-02
Post IPO Debt • $200.0M
2018-12-01
Post IPO Equity • $40.0M

Recent News

MannKind Corporation (NASDAQ:MNKD) Given Average Recommendation of "Moderate Buy" by Brokerages

Is MannKind Corporation (NNFN) stock attractive post correction - 2025 Market WrapUp & Accurate Buy Signal Alerts

What momentum indicators show for MannKind Corporation stock - Wall Street Watch & Expert Curated Trade Ideas

What momentum indicators show for MannKind Corporation stock - July 2025 Institutional & Verified Swing Trading Watchlist

Can swing trading help recover from MannKind Corporation losses

Is MannKind Corporation stock attractive for retirement portfolios - Market Risk Analysis & Risk Controlled Swing Alerts

Connor Clark & Lunn Investment Management Ltd. Decreases Position in MannKind Corporation $MNKD

How MannKind Corporation stock responds to policy changes - Portfolio Return Summary & Long-Term Capital Growth Ideas

Los Angeles Capital Management LLC Buys 177,440 Shares of MannKind Corporation $MNKD

MannKind to Present at the Jefferies Global Healthcare Conference

MannKind Corp (MNKD) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Expansions ...

Revenue Jump and Portfolio Expansion Could Be a Game Changer for MannKind (MNKD)

MANNKIND CORP SEC 10-Q Report

MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say

Simon Quick Advisors LLC Acquires Shares of 48,216 MannKind Corporation $MNKD

MannKind Corporation (NASDAQ:MNKD) Short Interest Up 37.4% in October

MannKind Corp (MNKD) Q3 2025 Earnings Report Preview: What to Expect

MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025

Quiver Quantitative

MannKind Corporation to Announce Q3 2025 Financial Results and Host Webcast on November 5, 2025

MannKind Corporation (NASDAQ:MNKD) Receives Average Recommendation of "Moderate Buy" from Brokerages

How analysts rate MannKind Corporation stock today - July 2025 Recap & Safe Capital Growth Stock Tips

How MannKind Corporation stock responds to policy changes - Weekly Trend Summary & Comprehensive Market Scan Insights

How MannKind Corporation stock responds to policy changes - Market Activity Report & Consistent Profit Trading Strategies

Is MannKind Corporation (NNFN) stock attractive post correction - 2025 Pullback Review & Weekly Return Optimization Alerts

Is MannKind Corporation (NNFN) stock attractive post correction - Profit Target & Verified Stock Trade Ideas

Earnings Beat: Is MannKind Corporation stock vulnerable to regulatory risks - Market Growth Summary & Reliable Price Action Trade Plans

Will MannKind Corporation stock remain a Wall Street favorite - 2025 Buyback Activity & AI Forecast Swing Trade Picks

Portfolio Shifts: Will MannKind Corporation stock remain a Wall Street favorite - Market Activity Report & Technical Buy Zone Confirmation

MannKind: Durable Cash Engine, Optional Catalysts Pending (NASDAQ:MNKD)

MannKind (MNKD) Is Down 9.9% After FDA Reviews Afrezza for Pediatric Use Will Growth Prospects Shift?

MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes

MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes

Quiver Quantitative

MannKind Corporation Submits Supplemental Biologics License Application for Needle-Free Afrezza Inhalation Powder for Pediatric Diabetes Treatment

MannKind completes acquisition of scPharmaceuticals in $296.5 million deal

Quiver Quantitative

MannKind Corporation Completes Acquisition of scPharmaceuticals Inc. to Enhance Growth in Cardiometabolic Care

MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care

Over $370M Annualized Run Rate — MannKind Completes Acquisition of scPharmaceuticals; $5.35 Cash

MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer

MNKD: HC Wainwright & Co. Reiterates Buy Rating with $11 Target | MNKD Stock News

H.C. Wainwright Reiterates a Buy Rating on MannKind Corporation (MNKD)

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

Latham & Watkins LLP

Latham & Watkins Advises scPharmaceuticals in Acquisition by MannKind Corporation

Leerink Partners Reiterates a Buy Rating on MannKind Corporation (MNKD), Keeps the PT at $7

Leerink Partners Reiterates a Buy Rating on MannKind Corporation (MNKD), Keeps the PT at $7

MannKind Corporation to Acquire scPharmaceuticals: More Details Inside

Leerink Partners Reiterates a Buy on MannKind Corporation (MNKD), Keeps the PT

MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline

MannKind Corporation (NASDAQ:MNKD) Q2 2025 Earnings Call Transcript

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind And Blackstone Announce Up To $500 Mln Strategic Financing Agreement

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

MannKind Corporation Reports Second Quarter 2025 Financial Resu

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind selloff on earnings overdone, says H.C. Wainwright

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

MannKind, Blackstone enter up to $500M strategic financing agreement

MannKind reports Q2 non-GAAP EPS 5c, consensus 8c

MannKind Corporation announced that it expects to receive $200 million in funding from Blackstone Alternative Credit Advisors LP

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

MannKind Corporation (MNKD) Presented Inhaled Insulin Therapy At American Diabetes Association

Research and Markets

Nontuberculous Mycobacteria (NTM) Opportunity Assessment and Forecast to 2033 Featuring Janssen, Novartis, Meiji Seika Pharma, Insmed, Daiichi Sankyo, MannKind, Paratek, Nobelpharma, GSK, Pfizer

MannKind assumed with a Buy at H.C. Wainwright

MannKind Corporation(NasdaqGM:MNKD) dropped from Russell Microcap Growth Index

MannKind (MNKD) Presents Pediatric Insulin Trial Data

Morningstar.com

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

Type 1 Diabetes Market Size to Reach USD 9.6 billion by 2035 | Epidemiology, Treatment, Trends & Rising Incidence

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23

INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29

MannKind to Present at Upcoming Investor Conferences

MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain

MannKind's Q1 Adjusted Earnings, Revenue Increase

MannKind Non-GAAP EPS of $0.07 beats by $0.01, revenue of $78.35M beats by $2.49M

MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025

MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025

Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Mizuho sets MannKind stock Outperform with $12 target

MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options

Research and Markets

Needle Free Diabetes Care Market Analysis and Forecast 2025-2030 - Closed-Loop Systems Becoming More Accessible, User-Friendly, and Effective

Short Acting Insulin Global Market Report 2025: Projected To Reach $14.47 Billion With A CAGR Of 5.6%

MannKind at Barclays Healthcare Conference: Strategic Growth and Innovation

MannKind Corporation Showcases Positive Outcomes of Inhaled Insulin at ATTD 2025 with Anticipated sNDA Filing for Pediatric Use in 2025

MannKind Advances Pediatric Inhaled Insulin Program with 5 Clinical Studies

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22

GlobeNewswire News Room

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22

MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

MannKind Corp (MNKD) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

StreetInsider.com

MannKind (MNKD) Files Mixed Shelf

Mannkind stock gains amid Q4 report, business update

StreetInsider.com

MannKind (MNKD) Files Mixed Shelf

MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025

GlobeNewswire News Room

MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025

Wedbush Initiates Coverage on MannKind (NASDAQ:MNKD) - MarketBeat

SG Americas Securities LLC Has $182,000 Holdings in MannKind Co. (NASDAQ:MNKD) - MarketBeat

MannKind To Present At Oppenheimer Healthcare Life Sciences Conference; Webcast At 11:20 AM ET - Nasdaq

Stock Traders Daily

(MNKD) Technical Data - Stock Traders Daily

MannKind (NASDAQ:MNKD) Coverage Initiated by Analysts at Wedbush - Defense World

MannKind Co. (NASDAQ:MNKD) Shares Sold by Calamos Advisors LLC - MarketBeat

Similar Jobs

Senior Field Marketing Manager

NICE

USA (Remote)

In-houseFull-timeSenior level7+ years exp.

Sr. Director of Field Marketing & ABX

StackAdapt

Cañada, Hidalgo, Mexico (Remote)

$200K/yr - $237K/yrIn-houseFull-timeSenior level7+ years exp.

Field Marketing Manager

Didero

USA (On-site)

In-houseFull-timeMid level4+ years exp.

Field & Partner Marketing Manager, West Region - San Jose, CA - 3 Days Onsite

Nile

San Jose, CA (On-site)

In-houseFull-timeSenior level8+ years exp.

Field Marketing Manager

Bath & Cabinet Experts

Terre Haute, IN (On-site)

In-houseFull-timeMid level2+ years exp.

Field Marketing Associate / Canvasser - SB

System Pavers

Hayward, CA (On-site)

In-houseFull-timeEntry level

View more Field Marketing jobs

Similar Jobs

View more Field Marketing jobs

Senior Field Marketing Manager

NICE

USA (Remote)

In-houseFull-timeSenior level7+ years exp.

Sr. Director of Field Marketing & ABX

StackAdapt

Cañada, Hidalgo, Mexico (Remote)

$200K/yr - $237K/yrIn-houseFull-timeSenior level7+ years exp.

Field Marketing Manager

Didero

USA (On-site)

In-houseFull-timeMid level4+ years exp.

Field & Partner Marketing Manager, West Region - San Jose, CA - 3 Days Onsite

Nile

San Jose, CA (On-site)

In-houseFull-timeSenior level8+ years exp.

Field Marketing Manager

Bath & Cabinet Experts

Terre Haute, IN (On-site)

In-houseFull-timeMid level2+ years exp.

Field Marketing Associate / Canvasser - SB

System Pavers

Hayward, CA (On-site)

In-houseFull-timeEntry level

View more Field Marketing jobs

SalaryGuide^™

The career intelligence platform for marketing professionals.

By Category

General Marketing Jobs
Social Media Jobs
Communications Jobs
Product Marketing Jobs
Growth Marketing Jobs
Event Marketing Jobs
Content Marketing Jobs
Public Relations Jobs
Paid Media Jobs
Community Management Jobs
View All Marketing Jobs

Remote Jobs

Remote General Marketing Jobs
Remote Social Media Jobs
Remote Communications Jobs
Remote Product Marketing Jobs
Remote Growth Marketing Jobs
Remote Event Marketing Jobs
Remote Content Marketing Jobs
Remote Public Relations Jobs
Remote Paid Media Jobs
Remote Community Management Jobs
View All Remote Marketing Jobs

By Work Style

Remote Marketing Jobs
On-Site Marketing Jobs
Hybrid Marketing Jobs

By Company Type

In-House Marketing Jobs
Marketing Agency Jobs

By Industry

Software
SaaS
Information Technology
Health Care
Financial Services
E-Commerce
Retail
Professional Services
Consulting
Media and Entertainment
Education
Real Estate
All industries

By Experience

Entry-Level Marketing Jobs
Mid-Level Marketing Jobs
Senior Marketing Jobs
Marketing Manager Jobs
Marketing Director Jobs

By Employment

Full-Time Marketing Jobs
Part-Time Marketing Jobs
Contract Marketing Jobs
Marketing Internships

Quick Links

Browse All Jobs
Salary Data
Companies
About Us
Contact Us

SalaryGuide^™

The #1 job board for marketing professionals. Find your next role in paid media, SEO, content, and more.

© 2025 SalaryGuide. All rights reserved.

Privacy PolicyTerms of ServiceRefund PolicyContact